Exactus (EXDI) Starts Presentation at LD Micro Main Event
Exactus (OTC: EXDI) is a life science company that develops and commercializes Point-of-Care (POC) diagnostics for measuring proteolytic enzymes in the blood based on a proprietary detection platform. Through the use of its proprietary technology, the company anticipates that the use of the FibriLyzer could provide the basis for improved management of patients who are at-risk of hemorrhage, speeding treatment decisions and potentially improving patient outcomes and saving money. For more information, visit the company's website at www.exactusdx.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…







